Federal Court Finds Actavis Applies Only To Settlements Involving Monetary Payments

by Pepper Hamilton LLP
Contact

A United States district court judge sitting in the District of New Jersey has held that only patent litigation settlements involving monetary payments from branded to generic pharmaceutical manufacturers are subject to the rule of reason under the Supreme Court’s landmark decision issued earlier this year, FTC v. Actavis. In a recent decision issued in In re Lamictal Direct Purchaser Antitrust Litigation, Judge William H. Walls is the first district court judge to limit the Supreme Court’s holding to settlements involving money. In so doing, he parts company with other district courts that have considered the issue in the wake of Actavis.

In Lamictal plaintiffs have challenged a patent litigation settlement between GlaxoSmithKline (GSK) and Teva. Plaintiffs allege that under the settlement agreement, GSK granted Teva exclusive licenses to market generic lamotrigine tablets and chewables prior to patent expiration, during which time GSK agreed not to market its own authorized generic. In December 2012, Judge Walls dismissed plaintiffs’ complaint with prejudice, finding that under the then-prevailing “quick look” test in the Third Circuit, the alleged agreement did not trigger antitrust scrutiny because the alleged agreement contained no “payment.” Plaintiffs appealed, and in July 2013, the Third Circuit remanded for reconsideration in light of the Supreme Court’s ruling in Actavis.

In Actavis, the Supreme Court rejected the Third Circuit’s “quick look” test, as well as the “scope of the patent” test embraced by other circuits. Instead, the Supreme Court held that because “large, unjustified reverse payments” made to settle patent litigation pose the risk of “significant anticompetitive effects,” large reverse payments should be analyzed under the traditional rule of reason analysis. In last week’s decision, Judge Walls, observing that the Actavis majority and dissenting opinions “reek with the discussion of payment of money,” agreed with GSK and Teva that Actavis subjects only monetary payments that are large and unjustified to antitrust scrutiny. Judge Walls held that “nothing in Actavis says that a settlement contains a reverse payment when it confers substantial financial benefits,” and reaffirmed his earlier reasoning that an exchange of “consideration” cannot in itself be sufficient to trigger antitrust scrutiny because “consideration is an essential element of any enforceable contract.” Further, Judge Walls acknowledged that two other federal judges have interpreted Actavis to potentially reach settlements that do not include monetary payments, but he expressly dismissed those decisions as “unpersuasive.”

Judge Walls found that Actavis prescribes a three-part test, under which a court must determine first whether there is a monetary reverse payment, and second whether the payment is large and unjustified. Only if these two prongs are met should a district court turn to the third part of the test: the rule of reason analysis. Under the rule of reason, Actavis requires district courts to consider (1) whether the payment has the potential for genuine adverse effects on competition, (2) whether the payment is justified, (3) whether the branded manufacturer has market power, (4) whether the size of the settlement suggests it is intended to maintain supracompetitive prices and that it can serve as a “workable surrogate for a patent’s weakness,” and (5) whether the parties could have settled in some other way. Applying these considerations, Judge Walls further found that even if antitrust review of plaintiffs’ allegations were warranted, plaintiffs failed to plead a rule of reason case. Plaintiffs have appealed the decision to the Third Circuit.

GSK is represented in this matter by Barbara W. Mather, Robin P. Sumner, Evan W. Davis and Melissa J. Hatch of Pepper Hamilton LLP.

Written by:

Pepper Hamilton LLP
Contact
more
less

Pepper Hamilton LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.